Chemotherapeutic Targeting of Etoposide to Various Tissues on the Basis of Polyamine Level

References

• Alm, K., Berntsson, P. and Oredsson, S.M. (1999) “Topoisomerase II is nonfunctional in polyamine-depleted cells”, J. Cell Biochem. 75, 46–55.
   PubMed Web of Science ®Google Scholar
• Carlson, R.W., Dorfman, R.F. and Sikic, B.I. (1990) “Successful treatment of metastatic thymic carcinoma with cisplatin, vinblas- tine, bleomycin, and etoposide chemotherapy”, Cancer 66, 2092–2094.
   PubMed Web of Science ®Google Scholar
• Cipolla, B., Guilli, F. and Moulinoux, J.P. (2003) “Polyamine-reduced diet in metastatic hormone-refractory prostate cancer (HRPC) patients”, Biochem. Soc. Trans. 31, 384–387.
   Google Scholar
• Clark, P.I. (1999) “Current role of oral etoposide in the management of small cell lung cancer”, Drugs 58(Suppl. 3), 17–20.
   PubMedGoogle Scholar
• Comis, R.L., Friedland, D.M. and Good, B.C. (1999) “The role of oral etoposide in non-small cell lung cancer”, Drugs 58(Suppl. 3), 21–30.
   Google Scholar
• Crist, W.M., Raney, R.B., Ragab, A., Heyn, R., Wharam, M., Webber, B., Johnston, J. and Beltangady, M. (1987) “Intensive chemotherapy including cisplatin with or without etoposide for children with soft- tissue sarcomas”, Med. Pediatr. Oncol. 15, 51–57.
   PubMedGoogle Scholar
• Duranton, B., Nsi-Emvo, E., Schleiffer, R., Gosse, F., Galluser, M. and Raul, F. (1997) “Suppression of preneoplastic changes in the intestine of rats fed low levels of polyamines”, Cancer Res. 57, 573–575.
   PubMed Web of Science ®Google Scholar
• Evans, S.R., Krown, S.E., Testa, M.A., Cooley, T.P. and Von Roenn, J.H. (2002) “Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi’s sarcoma: an AIDS Clinical Trials Group clinical study”, J. Clin. Oncol. 20, 3236–3241.
   Web of Science ®Google Scholar
• Hegardt, C., Johannsson, O.T. and Oredsson, S.M. (2002) “Rapid caspase-dependent cell death in cultured human breast cancer cells induced by the polyamine analogue N(1),N(11)-diethylnorspermine”, Eur. J. Biochem. 269, 1033–1039.
   Web of Science ®Google Scholar
• Hougaard, D.M. (1992) “Polyamine cytochemistry: localization and possible functions of polyamine”, Int. Rev. Cytol. 138, 51–81.
   PubMed Web of Science ®Google Scholar
• Hussain, M.H., Pienta, K.J., Redman, B.G., Cummings, G.D. and Flaherty, L.E. (1994) “Oral etoposide in the treatment of hormone- refractory prostate cancer”, Cancer 74, 100–103.
   PubMed Web of Science ®Google Scholar
• Jazieh, A.R., Kyasa, M.J. and Muirhead, M.J. (2002) “Prolonged administration of infusional cisplatin and oral etoposide in advanced non-small cell lung cancer”, Anticancer Drugs 13, 815–818.
   PubMed Web of Science ®Google Scholar
• Jett, J.R., Hatfield, A.K., Hillman, S., Bauman, M.D., Mailliard, J.A., Kugler, J.W., Morton, R.F., Marks, R.S. and Levitt, R. (2003) “Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group”, Cancer 97, 2498–2503.
   PubMed Web of Science ®Google Scholar
• Kamradt, J.M. and Pienta, K.J. (2000) “Etoposide in prostate cancer”, Expert Opin. Pharmacother. 1, 271–275.
   Google Scholar
• Korhonen, V.P., Niiranen, K., Halmekyto, M., Pietila, M., Diegelman, P., Parkkinen, J.J., Eloranta, T., Porter, C.W., Alhonen, L. and Janne, J. (2001) “Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to antiproliferative drugs”, Mol. Pharmacol. 59, 231–238.
   Web of Science ®Google Scholar
• Lindsay, G.S. and Wallace, H.M. (1999) “Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis”, Biochem. J. 337, 83–87.
   PubMed Web of Science ®Google Scholar
• Marton, L.J. and Pegg, A.E. (1995) “Polyamines as targets for therapeutic intervention”, Annu. Rev. Pharmacol. Toxicol. 35, 55–91.
   PubMed Web of Science ®Google Scholar
• Mascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J.J., Lemaitre, F., Meert, A.P., Vermylen, P. and Sculier, J.P. (2000) “A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis”, Lung Cancer 30, 23–36.
   PubMed Web of Science ®Google Scholar
• Pegg, A.E. (1988) “Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy”, Cancer Res. 48, 759–774.
   PubMed Web of Science ®Google Scholar
• Porter, C.W., Ganis, B., Libby, P.R. and Bergeron, R.J. (1991) “Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines”, Cancer Res. 51, 3715–3720.
   PubMed Web of Science ®Google Scholar
• Quemener, V., Moulinoux, J.P., Havouis, R. and Seiler, N. (1992) “Polyamine deprivation enhances antitumoral efficacy of chemother- apy”, Anticancer Res. 12, 1447–1454.
   PubMed Web of Science ®Google Scholar
• Quemener, V., Blanchard, Y., Chamaillard, L., Havouis, R., Cipolla, B. and Moulinoux, J.P. (1994) “Polyamine deprivation: a new tool in cancer Treatment”, Anticancer Res. 41, 443–448.
   Google Scholar
• Ray, R.M., Viar, M.J., Yuan, Q. and Johnson, L.R. (2000) “Polyamine depletion delays apoptosis of rat intestinal epithelial cells”, Am. J. Physiol. Cell Physiol. 278, 480–489.
   PubMed Web of Science ®Google Scholar
• Seiler, N. and Knodgen, B. (1980) “High-performance liquid chromato- graphic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives”, J. Chromatogr. 221, 227–236.
   Google Scholar
• Stefanelli, C., Tantini, B., Fattori, M., Stanic, I., Pignatti, C., Clo, C., Guarnieri, C., Caldarera, C.M., Mackintosh, C.A., Pegg, A.E. and Flamigni, F. (2002) “Caspase activation in etoposide- treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion”, FEBS Lett. 527, 223–228.
   PubMed Web of Science ®Google Scholar
• Sun, X.M., Carthew, P., Dinsdale, D., Snowden, R.T. and Cohen, G.M. (1994) “The involvement of apoptosis in etoposide-induced thymic atrophy”, Toxicol. Appl. Pharmacol. 128, 78–85.
   PubMed Web of Science ®Google Scholar
• Sundstrom, S., Bremnes, R.M., Kaasa, S., Aasebo, U., Hatlevoll, R., Dahle, R., Boye, N., Wang, M., Vigander, T., Vilsvik, J., Skovlund, E., Hannisdal, E. and Aamdal, S. (2002) “Norwegian Lung Cancer Study Group, Cisplatin and etoposide regimen is superior to cyclopho- sphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years follow- up”, J. Clin. Oncol. 20, 4665–4672.
   Web of Science ®Google Scholar
• Tfayli, A., Hentschel, P., Madajewicz, S., Manzione, J., Chowhan, N., Davis, R., Roche, P., Iliya, A., Roque, C., Meek, A. and Shady, M. (1999) “Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors”, J. Neurooncol. 42, 73–77. Thomas, T. and Thomas, T.J. (2001) “Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications”, Cell Mol. Life Sci. 58, 244–258.
   Google Scholar
• Thomas, T., Balabhadrapathruni, S., Gallo, M.A. and Thomas, T.J. (2002) “Development of polyamine analogs as cancer therapeutic agents”, Oncol. Res. 13, 123–135.
   Google Scholar
• Wallace, H.M. and Fraser, A.V. (2003) “Polyamine analogues as anticancer drugs”, Biochem. Soc. Trans. 31, 393–396.
   Google Scholar
• Walther, P.J., Williams, S.D., Troner, M., Greco, F.A., Birch, R. and Einhorn, L.H. (1986) “Phase II study of etoposide for carcinoma of the prostate”, Cancer Treat. Rep. 70, 771–772.
   Google Scholar
• Watanabe, S., Sato, S., Nagase, S., Tomita, M., Saito, T. and Ishizu, H. (1992) “Automated quantitation of polyamines by improved cation- exchange high-performance liquid chromatography using a pump equipped with a plunger washing system”, J. Liquid Chromatogr. 16, 619–632.
   Google Scholar
• Watanabe, S., Sato, S., Nagase, S. and Saito, T. (1996) “Therapeutic significance of the polyamine level in tissues of rats treated with adriamycin and cisplatin”, Anti-Cancer Drugs 7, 114–120.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., Sato, S., Nagase, S., Shimosato, K. and Ohkuma, S. (2002) “Chemotherapeutic targeting of etoposide to regions of the brain on the basis of polyamine level”, J. Drug Target. 10, 457–461.
   PubMed Web of Science ®Google Scholar